ProShares UltraPro Nasdaq Biotechnology (UBIO)
ProShares UltraPro Nasdaq Biotechnology (UBIO) reported 225 holdings in its SEC Form NPORT-P for the period ended 2020-02-29.
No stock price history for UBIO on this site yet.
SEC Form NPORT-P as filed (series S000049733), accession 0001752724-20-082285.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF (IBBQ) | United States | $0.076B | 47.62% |
| iShares Biotechnology ETF (IBB) | United States | $8.123B | 46.92% |
| ProShares Ultra Nasdaq Biotechnology (BIB) | United States | $0.092B | 40.92% |
| VanEck Biotech ETF (BBH) | United States | $0.372B | 40.87% |
| Invesco Biotechnology & Genome ETF (PBE) | United States | $0.247B | 34.56% |
| First Trust NYSE Arca Biotechnology Index Fund (FBT) | United States | $2.270B | 34.24% |
| iShares Evolved U.S. Innovative Healthcare ETF (IEIH) | 34.11% | ||
| First Trust Nasdaq Pharmaceuticals ETF (FTXH) | United States | $0.029B | 28.92% |
| Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) | United States | $0.003B | 25.57% |
| Virtus Biotech Etf (BBP) | United States | $0.059B | 24.58% |